T2 Biosystems Inc (TTOO):企業の製品パイプライン分析

◆英語タイトル:T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME16364PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥192,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥288,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. The company also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. T2 Biosystems products provide species-specific identification directly from whole blood. The company offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians’ offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company T2 Biosystems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
T2 Biosystems Inc Company Overview
T2 Biosystems Inc Company Snapshot
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
T2 Biosystems Inc – Pipeline Analysis Overview
T2 Biosystems Inc – Key Facts
T2 Biosystems Inc – Major Products and Services
T2 Biosystems Inc Pipeline Products by Development Stage
T2 Biosystems Inc Pipeline Products Overview
Next Generation T2Dx Instrument
Next Generation T2Dx Instrument Product Overview
T2Carba Resistance+
T2Carba Resistance+ Product Overview
T2Dx – Biothreat Panel
T2Dx – Biothreat Panel Product Overview
T2Dx – Cancer
T2Dx – Cancer Product Overview
T2Dx – Cardiac
T2Dx – Cardiac Product Overview
T2Dx – Comprehensive Panel
T2Dx – Comprehensive Panel Product Overview
T2Endotoxin
T2Endotoxin Product Overview
T2HemoStat
T2HemoStat Product Overview
T2Lyme Panel
T2Lyme Panel Product Overview
T2MR Assay – Platelet Function Testing
T2MR Assay – Platelet Function Testing Product Overview
T2Plex
T2Plex Product Overview
T2Resistance Panel
T2Resistance Panel Product Overview
T2Resistance Panel – Expansion
T2Resistance Panel – Expansion Product Overview
T2 Biosystems Inc – Key Competitors
T2 Biosystems Inc – Key Employees
T2 Biosystems Inc – Key Employee Biographies
T2 Biosystems Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
T2 Biosystems Inc, Recent Developments
Feb 04, 2020: T2 Biosystems announces participation at Clinical Conferences in February
Jan 13, 2020: T2 Biosystems promotes Tony Pare to Chief Commercial Officer
Jan 09, 2020: T2 Biosystems appoints industry veteran John Sperzel as chief executive officer
Jan 09, 2020: T2 Biosystems announces preliminary fourth quarter 2019 financial results
Nov 20, 2019: T2 Biosystems announces granting of CE-Mark for T2Resistance Panel
Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update
Nov 07, 2019: T2 Biosystems to share early data at the World Anti-Microbial Resistance Congress
Oct 02, 2019: T2 Biosystems to Showcase Latest Innovations at IDWeek 2019
Sep 30, 2019: T2 Biosystems T2Resistance Panel is now available as a Research Use Only (RUO) Test in the U.S.
Sep 24, 2019: T2 Biosystems’ T2Resistance panel is first diagnostic to graduate from CARB-X Portfolio
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
T2 Biosystems Inc Pipeline Products by Equipment Type
T2 Biosystems Inc Pipeline Products by Indication
T2 Biosystems Inc, Key Facts
T2 Biosystems Inc, Major Products and Services
T2 Biosystems Inc Number of Pipeline Products by Development Stage
T2 Biosystems Inc Pipeline Products Summary by Development Stage
Next Generation T2Dx Instrument - Product Status
Next Generation T2Dx Instrument - Product Description
T2Carba Resistance+ - Product Status
T2Carba Resistance+ - Product Description
T2Dx - Biothreat Panel - Product Status
T2Dx - Biothreat Panel - Product Description
T2Dx - Cancer - Product Status
T2Dx - Cancer - Product Description
T2Dx - Cardiac - Product Status
T2Dx - Cardiac - Product Description
T2Dx - Comprehensive Panel - Product Status
T2Dx - Comprehensive Panel - Product Description
T2Endotoxin - Product Status
T2Endotoxin - Product Description
T2HemoStat - Product Status
T2HemoStat - Product Description
T2Lyme Panel - Product Status
T2Lyme Panel - Product Description
T2MR Assay - Platelet Function Testing - Product Status
T2MR Assay - Platelet Function Testing - Product Description
T2Plex - Product Status
T2Plex - Product Description
T2Resistance Panel - Product Status
T2Resistance Panel - Product Description
T2Resistance Panel - Expansion - Product Status
T2Resistance Panel - Expansion - Product Description
T2 Biosystems Inc, Key Employees
T2 Biosystems Inc, Key Employee Biographies
T2 Biosystems Inc, Other Locations
Glossary

★海外企業調査レポート[T2 Biosystems Inc (TTOO):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Cegedim SA (CGM):企業の財務・戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is a technology company that offers healthcare technical services. The company offers solutions to facilitate business and medical operations. It offers health and preventive health management software used in management of individual and collective health and preventive …
  • First Republic Bank:企業の戦略・SWOT・財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • Allscripts Healthcare Solutions Inc (MDRX)-医療機器分野:企業M&A・提携分析
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management solutions, Population Health Manag …
  • Public Service Enterprise Group Inc (PEG)-エネルギー分野:企業M&A・提携分析
    Summary Public Service Enterprise Group Inc. (PSEG) is a diversified energy holding company that generates, transmits and distributes electricity, and gas. It supplies electricity from its nuclear, fossil and renewable energy assets as part of its wholesale energy activities. The company sells elect …
  • Airasia Group Berhad:企業の戦略・SWOT・財務分析
    Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • James Fisher and Sons Plc (FSJ):電力:M&Aディール及び事業提携情報
    Summary James Fisher and Sons Plc (James Fisher) is a service provider for global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as design and engineering; inspection and monitoring; lifting and handling; mar …
  • Team Health Holdings Inc (TMH):企業の財務・戦略的SWOT分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care and healthcare services. The organization’s services include hospital medicine, emergency medicine, anesthesiology, hospital medicine subspecialties, ambulatory care, post-acute care, and behavioral h …
  • Ball Aerospace & Technologies Corp.:企業の戦略・SWOT・財務情報
    Ball Aerospace & Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary Ball Aerospace & Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Yamato Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dalet S.A. (DLT):企業の財務・戦略的SWOT分析
    Dalet S.A. (DLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MediGene AG (MDG1):製薬・医療:M&Aディール及び事業提携情報
    Summary MediGene AG (MediGene) is a biotechnology company which develops drugs for the treatment of various types and stages of cancer with candidates in clinical and pre-clinical development. The company focuses on the development of personalized T-cell-based immunotherapies. Its core business deve …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MedDay SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for nervous system disorders. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism to treat elucidation of metabolism pathways in the brain. Its pipeline products compri …
  • Infineon Technologies AG (IFX):企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kraton Polymers LLC:企業の戦略的SWOT分析
    Kraton Polymers LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆